Dihydroceramides in Triglyceride-Enriched VLDL Are Associated with Nonalcoholic Fatty Liver Disease Severity in Type 2 Diabetes - ScienceDirect
The diagnostic performance of a simplified blood test (SteatoTest-2) for the prediction of liver steatosis. - Abstract - Europe PMC
Fibromax
Diagnostics | Free Full-Text | Diagnostic Modalities of Non-Alcoholic Fatty Liver Disease: From Biochemical Biomarkers to Multi-Omics Non-Invasive Approaches
Nonalcoholic Fatty Liver Disease: Review of Management for Primary Care Providers - Mayo Clinic Proceedings
Current and Emerging Biomarkers and Imaging Modalities for Nonalcoholic Fatty Liver Disease: Clinical and Research Applications - ScienceDirect
Utility of noninvasive methods for the characterization of nonalcoholic liver steatosis in the family practice. The “VARES” Italian multicenter study | Annals of Hepatology
Comparison of fatty liver index with noninvasive methods for steatosis detection and quantification
PDF) How can we predict steatosis using biochemical markers (SteatoTest and Fatty liver index)?
Performance of the SteatoTest, ActiTest, NashTest and FibroTest in a multiethnic cohort of patients with type 2 diabetes mellitus | Journal of Investigative Medicine
Dihydroceramides in Triglyceride-Enriched VLDL Are Associated with Nonalcoholic Fatty Liver Disease Severity in Type 2 Diabetes - ScienceDirect
BioPredictive · FibroMax
Non-invasive assessment of non-alcoholic fatty liver disease: Clinical prediction rules and blood-based biomarkers - ScienceDirect
Utility of noninvasive methods for the characterization of nonalcoholic liver steatosis in the family practice. The “VARES” Italian multicenter study | Annals of Hepatology
Biomedicines | Free Full-Text | Effects of Achieving Sustained Virologic Response after Direct-Acting Antiviral Agents on Long-Term Liver Fibrosis in Diabetics vs. in Non-Diabetic Patients with Chronic Hepatitis C Infection
How can we predict steatosis using biochemical markers (SteatoTest and Fatty liver index) | Semantic Scholar
Nonalcoholic Fatty Liver Disease: Diagnosis and Management | AAFP
Diagnostic performance of FibroTest, SteatoTest and ActiTest in patients with NAFLD using the SAF score as histological reference | Request PDF
Performance of Biomarkers FibroTest, ActiTest, SteatoTest, and NashTest in Patients with Severe Obesity: Meta Analysis of Individual Patient Data | PLOS ONE
Comparison of fatty liver index with noninvasive methods for steatosis detection and quantification
The diagnostic performance of a simplified blood test (SteatoTest-2) for the prediction of liver steatosis
The diagnostic performance of a simplified blood test (SteatoTest-2) for the prediction of liver steatosis
Biomedicines | Free Full-Text | Effects of Achieving Sustained Virologic Response after Direct-Acting Antiviral Agents on Long-Term Liver Fibrosis in Diabetics vs. in Non-Diabetic Patients with Chronic Hepatitis C Infection
